CIBMTR

NEW: CIBMTR Research Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A CIBMTR analysis Read more: 🔗pubmed.ncbi.nlm.nih.gov/4277…

NEW: CIBMTR Research Group sequential clinical trial designs for composite endpoints incorporating recurrent and terminal events Read more: 🔗pubmed.ncbi.nlm.nih.gov/4249…

Some medicines given after transplant have unique effects. Read about this BMT CTN study to learn more: cibmtr.org/Patient-Summaries…

Just published: The November 2026 Newsletter from CIBMTR. Explore insights on kidney health in transplantation, working committee updates, new data resources, and recent research advances in HCT and cellular therapy. cibmtr.org/CIBMTR/About/News…

New: CIBMTR Research Cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome following axicabtagene ciloleucel or brexucabtagene CAR-T: CIBMTR research data Read more: 🔗pubmed.ncbi.nlm.nih.gov/4253…

New: CIBMTR Research GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches Read more: 🔗pubmed.ncbi.nlm.nih.gov/4257…

New: CIBMTR Research Challenges with expansion of cell and gene therapy: A call for system-level action Read more: 🔗pubmed.ncbi.nlm.nih.gov/4258…

JUST PUBLISHED TODAY: GVHD prophylaxis shapes T cell biology and immune reconstitution after HCT. Explore the latest @BMTCTN research here: science.org/doi/10.1126/scit… #HCT #GVHD #Research #CIBMTR #BMTCTN

🚨 Secure your spot at #Tandem27! Join HCT, cellular therapy, and gene therapy professionals for cutting-edge science, expert education, and valuable networking. Orlando, FL | 📅 Feb. 17-20, 2027 Register: tandemmeetings.com/Registrat…

New: CIBMTR Research Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: Results from the ACCESS trial Read more: 🔗 pubmed.ncbi.nlm.nih.gov/4261…

New: BMT CTN Research Donor-specific transplant outcomes from BMT CTN 1702: A multicenter prospective biologic assignment trial Read more: 🔗pubmed.ncbi.nlm.nih.gov/4226…

Looking to learn, connect, and collaborate? #Tandem27 brings together the HCT and cellular therapy community for four days of education, networking, and discovery. 📍 Orlando, FL | 📅 Feb. 17-20, 2027 Register: tandemmeetings.com/Registrat…

New: BMT CTN Research Patient-reported outcomes in clinical trials: Lessons from the BMT CTN Read more: 🔗pubmed.ncbi.nlm.nih.gov/4264…

🚨Last chance! Abstract submissions for the 2027 Tandem Meetings close tonight at 11:59 p.m. CT. If you've been putting finishing touches on your research, now's the time to submit for your chance to present. 📍Orlando, FL | Feb. 17-20, 2027 🔗tandemmeetings.com/Abstracts…

NEW: BMT CTN Research Interpreting cord blood transplant outcomes in BMT CTN 1702 Read more: 🔗pubmed.ncbi.nlm.nih.gov/4264…

🚨 Don't miss your chance to submit an abstract for #Tandem27 Abstract submissions close tomorrow, Oct. 9, at 11:59 p.m. CT. Submit your latest research before time runs out! ⏰ 📍 Orlando, FL | Feb. 17-20, 2027 🔗 tandemmeetings.com/Abstracts…

📢 #Tandem27 registration is open! Join ASTCT and CIBMTR for the latest research, emerging therapies, and advances in transplantation and cellular therapy. 📍 Orlando, FL | 📅 Feb. 17-20, 2027 Register: tandemmeetings.com/Registrat…

⏳ The countdown is on! Abstract submissions for #Tandem27 close this Friday, Oct. 9, at 11:59 p.m. CT. Share your latest research and connect with leaders in HCT, cellular therapy, and gene therapy. 📍 Orlando, FL | Feb. 17-20, 2027 🔗 tandemmeetings.com/Abstracts…

NEW: CIBMTR Research Fertility preservation in 2026: Current landscape in Europe and the United States for children and adolescents undergoing HCT-recommendations on behalf of the Westhafen Intercontinental Group Read more: 🔗pubmed.ncbi.nlm.nih.gov/4212…